Active not recruitingOBSERVATIONAL

Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy

This study, called TABAC STOP ORL POUMON, wants to understand why some people with head, neck, or lung cancer manage to stop smoking for good after their treatment. Patients receiving radiotherapy or a combination of chemotherapy and radiotherapy will be involved. Researchers will follow about 100 patients for a year after their treatment finishes, checking in at one, six, and twelve months. The main goal is to find out how many patients are still smoke-free after six months. They also want to identify what factors help people quit, what makes them start smoking again, and how their smoking habits change over time. This information could help doctors better support cancer patients who want to stop smoking.

At a glance

Status

Active not recruiting

Sponsor

Centre Oscar Lambret

Enrolment target

100

Start

28 Mar 2022

Estimated completion

01 Nov 2026

Smoking Cessation Nicotine Addiction Nicotine Dependence Smoking Head and Neck Neoplasms

What is this study about?

When someone is diagnosed with cancer, it can be a really challenging time, and doctors often advise stopping smoking to improve treatment success and overall health. This particular study, called TABAC STOP ORL POUMON, is interested in patients who have head and neck cancer or lung cancer and are receiving treatment like radiotherapy or a combination of chemotherapy and radiotherapy. The main goal is to understand what helps these patients stay smoke-free in the long run after their cancer treatment.

The researchers will be carefully observing a group of about 100 patients. They are looking to see what helps people quit smoking and, just as importantly, what might make them start smoking again. They're also tracking how people's smoking habits change over a year after they finish their cancer treatment. This is an 'observational' study, meaning the doctors won't be giving new medicines or treatments specifically for this study; instead, they will be watching and recording information about patients who are already receiving standard cancer care.

The study will follow patients for 12 months after their treatment finishes, checking in with them at certain points. The information gathered from these patients will be really valuable. By understanding the different reasons why some people successfully quit smoking and others struggle, doctors can develop better ways to support future cancer patients in their journey to become smoke-free. This could lead to better health outcomes for many people.

Key takeaways

This study helps understand why cancer patients stop smoking long-term.
It focuses on head, neck, or lung cancer patients receiving curative radiotherapy or chemoradiotherapy.
Participation involves questionnaires and follow-up check-ins for 12 months.
No new treatments or medicines are given as part of the study.
Your involvement helps improve support for future patients wanting to quit smoking.

Who may be eligible?

This study is looking for volunteers who are 18 years old or older. You would need to have been diagnosed with either head and neck cancer or lung cancer. Importantly, you should be receiving treatment that involves radiotherapy, or a combination of chemotherapy and radiotherapy, with the aim of curing your cancer.

You also need to be someone who currently smokes or used to smoke. If you are receiving treatment specifically to ease symptoms (palliative care) rather than to cure your cancer, this study would not be suitable for you. Additionally, participants need to be covered by a social security scheme, which most people in the UK are.

Before joining, you'll be given all the information about the study and will need to agree to take part and allow your information to be collected. This is called 'giving your consent'.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you have head or neck cancer, or lung cancer?
Are you having radiotherapy or chemoradiotherapy to cure your cancer?
Do you currently smoke or have you smoked in the past?
Are you covered by a social security scheme (e.g., NHS in the UK)?
Are you willing to give your agreement to have your information collected?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you'll be asked to complete some questionnaires during your final week of cancer treatment. These questions will ask about your smoking habits and how much you rely on nicotine, as well as any alcohol use. After your treatment ends, the study team will get in touch with you for follow-up check-ins at one month, six months, and twelve months. These follow-ups might be during a visit to the clinic or a phone call, depending on what's easiest. No new medications are given as part of this study, and the total duration of your involvement would be 12 months from when your treatment finishes.

Potential risks and benefits

The main benefit of taking part in this study is contributing valuable information that could help future cancer patients quit smoking and improve their health. For you personally, there's no direct medical benefit or change to your cancer treatment. The risks are very low, mainly involving the time it takes to complete questionnaires and participate in follow-up calls or visits. You are free to withdraw from the study at any time, for any reason, without it affecting your ongoing medical care.

Locations (1)

Centre Oscar Lambret
Verified postcode
Lille, France

Common questions

What kind of cancer patients are being studied?

The study is looking at patients with head and neck cancer or lung cancer who are receiving treatment to cure their cancer.

What kind of treatment will I be receiving if I join?

You would be receiving radiotherapy, or a combination of chemotherapy and radiotherapy, as part of your standard cancer care.

How long will I be involved in the study?

You'll be part of the study for 12 months after your cancer treatment finishes.

Will I have to take any new medicines?

No, this study doesn't involve any new medicines. It's about observing your smoking habits and collecting information.

What happens if I change my mind about taking part?

You can withdraw from the study at any time, and it won't affect your medical care.